Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
Palma-Álvarez, Raúl Felipe (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Ros-Cucurull, Elena (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Daigre, Constanza (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Perea-Ortueta, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Serrano-Pérez, Pedro (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Martínez-Luna, Nieves (Hospital Universitari Vall d'Hebron)
Salas-Martínez, Anna (Hospital Universitari Vall d'Hebron)
Robles-Martínez, María (Institut Hospital del Mar d'Investigacions Mèdiques)
Ramos-Quiroga, Josep Antoni (Centro de Investigación Biomédica en Red de Salud Mental)
Roncero, Carlos (Universidad de Salamanca)
Grau-López, Lara (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)

Data:	2021
Resum:	Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates alexithymia in Spanish patients with SUD and the relationship among alexithymia, psychiatric comorbidities, psychological symptoms/traits, SUD variables, and health-related quality of life (HRQoL). Methodology: A cross-sectional study was conducted with 126 Spanish outpatients with SUD (75. 4% males; mean age 43. 72 ± 14. 61 years), correlating their alexithymia levels (using the Toronto Alexithymia Scale 20 [TAS-20]) to their psychiatric comorbidities, psychological symptoms/traits, SUD variables, and HRQoL. Results: Alexithymia was significantly higher in patients who had cannabis use disorder. Higher alexithymia scores were also related to higher levels of depression, anxiety, impulsivity, and lower HRQoL. After multivariate analysis, trait anxiety, impulsivity, and the physical component summary of the HRQoL were found to be independently related to alexithymia. Conclusions: SUD patients with higher alexithymia levels have more frequently psychiatric comorbidities, present specific psychological features, and have worse HRQoL. Hence, it is important to evaluate these factors and offer more accurate psychotherapeutic approaches for this patient population.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Alexithymia ; Anxiety ; Depression ; Health-related quality of life ; Impulsivity ; Substance use disorder
Publicat a:	Frontiers in psychiatry, Vol. 12 (april 2021) , ISSN 1664-0640

DOI: 10.3389/fpsyt.2021.659063
PMID: 33897505

9 p, 230.8 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats